| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/28/2001 | WO2001046224A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001046214A2 Compound comprising a nucleic acid moiety and an organo-silane moiety |
| 06/28/2001 | WO2001046213A2 Compound comprising a peptide moiety and an organo-silane moiety. |
| 06/28/2001 | WO2001046175A1 Diamidine compounds as dna minor groove binders |
| 06/28/2001 | WO2001045845A1 Apparatus for performing heat-exchanging, chemical reactions |
| 06/28/2001 | WO2001045836A2 Molecules derived from mechanism based drug design |
| 06/28/2001 | WO2001045755A2 Method and applicator for detecting cleaning and/or disinfection of surfaces or objects |
| 06/28/2001 | WO2001045752A1 Interventions to mimic the effects of calorie restriction |
| 06/28/2001 | WO2001045730A2 Tweak receptor |
| 06/28/2001 | WO2001045495A2 Potassium channel stress-related proteins and methods of use in plants |
| 06/28/2001 | WO2001045494A2 Pyrophosphatase stress-related proteins and methods of use in plants |
| 06/28/2001 | WO2001045493A2 Transcription factor stress-related proteins and methods of use in plants |
| 06/28/2001 | WO2001045492A2 Protein kinase stress-related proteins and methods of use in plants |
| 06/28/2001 | WO2001040464A8 Interleukin-1-receptor associated kinase-3 (irak3) and its use in promotion or inhibition of angiogenesis and cardiovascularization |
| 06/28/2001 | WO2001003686A3 Inhibitors of staphylococcus sara protein and their use in treating staphylococcal infections |
| 06/28/2001 | WO2001002827A3 Biosensor |
| 06/28/2001 | WO2001002561A3 Mammalian calcium channels and related probes, cell lines and methods |
| 06/28/2001 | WO2000075364A3 Nmr rapid identification of bi-ligand drug candidates |
| 06/28/2001 | WO2000075167A9 Phosphorylation assays |
| 06/28/2001 | WO2000073452A3 Compositions and methods for the treatment of immune related diseases |
| 06/28/2001 | WO2000071741A3 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 06/28/2001 | WO2000070049A3 Extracellular signaling molecules |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000068247A3 Serine proteases |
| 06/28/2001 | WO2000066708A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/28/2001 | WO2000061814A9 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma |
| 06/28/2001 | WO2000061753A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/28/2001 | WO2000061180A3 Products and methods for treating ptp lar related diseases |
| 06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
| 06/28/2001 | WO2000044774A3 Inhibition of stat3 signal transduction for human cancer therapy |
| 06/28/2001 | WO2000037683B1 HIGH THROUGHPUT ASSAY SYSTEM FOR MONITORING ESTs |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/28/2001 | WO1999046575A3 Peptides containing a cholesterol recognition sequence and their uses |
| 06/28/2001 | US20010005774 Automatic electrophysiological measuring apparatus / method |
| 06/28/2001 | US20010005718 Apparatus and process for rapid hybridization |
| 06/28/2001 | US20010005588 A solid carrier where nucleotides are fixed by covalent bonding by a reaction of a reactive group on the carrier and a reactive group on the nucleotide using a transition metal catalyst; no blocking procedure; hydbridization; |
| 06/28/2001 | US20010005586 High speed selective identification, indivisual targeting with an energy beam, specific cells within a cell population for the purpose of inducing a response in the targeted cells, without affecting cells that are not being targeted |
| 06/28/2001 | US20010005584 Subjecting a 1,2-dioxetanes chemiluminescent substrate to an enzyme reaction in presence of enzymes selected from acid or alkaline phosphatase or galactosidase, a quaternary ammmonium intensity adjusting agent and a chemiluminescence enhancer |
| 06/28/2001 | US20010005580 Histamine measuring apparatus and a histamine measuring method |
| 06/28/2001 | DE19959857C1 Testsystem zum Nachweis von Analyten sowie ein Verfahren zur Herstellung und Verwendung Test system for detection of analytes and a method of making and using |
| 06/28/2001 | DE19958961A1 New plant nucleic acid transcribed quickly after pathogen infection, useful e.g. for increasing pathogen resistance of crops, especially potatoes against Phytophthora infestans |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | DE19956203A1 Controlling performance of complex polymerase chain reaction amplification, useful e.g. for genotyping, using a set of many specific primers and non-specific counter-strand primers |
| 06/28/2001 | DE19953854A1 Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften A process for the production of biopolymers with modified properties |
| 06/28/2001 | DE10064190A1 Exposing luminous screen to radiation, useful particularly for evaluating DNA microarrays, with application of magnetic or electrical field to increase resolution |
| 06/28/2001 | DE10036175A1 Determining activity of nucleic acid, useful for optimizing therapeutic or diagnostic nucleic acids, by transforming organisms, in parallel, with many different sequences |
| 06/28/2001 | DE10018959A1 Electric current type biosensor for detecting bio-component content or concentration in sample has multiple sampling paths |
| 06/28/2001 | CA2397844A1 Method for analyzing nucleic acid sequences |
| 06/28/2001 | CA2395578A1 Replication incompetent herpes virus vectors |
| 06/28/2001 | CA2395576A1 Replication incompetent herpes viruses for use in gene therapy |
| 06/28/2001 | CA2395525A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2395483A1 Method for obtaining information about dna mixtures |
| 06/28/2001 | CA2395466A1 Interventions to mimic the effects of calorie restriction |
| 06/28/2001 | CA2395369A1 Cytokine zcyto18 |
| 06/28/2001 | CA2395286A1 Aspartyl proteases |
| 06/28/2001 | CA2395239A1 Rna polymerases from bacteriophage phi 6-phi 14 and use thereof |
| 06/28/2001 | CA2395228A1 Pathologically modified myocardial cell, production and use thereof |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395102A1 Human kinases |
| 06/28/2001 | CA2395093A1 Mammalian protein phosphatases |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394974A1 Method of nucleic acid detection using target-specific assays |
| 06/28/2001 | CA2394942A1 Deposited thin films and their use in detection, attachment, and bio-medical applications |
| 06/28/2001 | CA2394789A1 Proteases |
| 06/28/2001 | CA2394743A1 Inhibition of .beta.arrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia |
| 06/28/2001 | CA2394652A1 Probes and primers for the detection of polyphosphate accumulating organisms in wastewater |
| 06/28/2001 | CA2394618A1 Method for isolation of rna from formalin-fixed paraffin-embedded tissue specimens |
| 06/28/2001 | CA2394049A1 Vesicle trafficking proteins |
| 06/28/2001 | CA2394015A1 Tweak receptor |
| 06/28/2001 | CA2393849A1 System and method for automated matched ion polynucleotide chromatography |
| 06/28/2001 | CA2393767A1 Molecules derived from mechanism based drug design |
| 06/28/2001 | CA2393500A1 Methods and compositions for detecting hepatitis e virus |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2392777A1 Methods of identifying compounds that bind to target species under isothermal denaturing conditions |
| 06/28/2001 | CA2392150A1 Diamidine compounds as dna minor groove binders |
| 06/28/2001 | CA2391594A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2391314A1 Multispecies food testing and characterization |
| 06/28/2001 | CA2361643A1 Analysis of nucleotide polymorphisms at a site |
| 06/28/2001 | CA2329608A1 Chemiluminescent assay |
| 06/28/2001 | CA2327533A1 A method for typing polymorphisms of bovine mhc class ii genes |
| 06/27/2001 | EP1111388A1 Interaction between CD14 and HBV components |
| 06/27/2001 | EP1111387A1 Method for detecting kidney diseases and pathological control |
| 06/27/2001 | EP1111069A1 Modified nucleic acids and their use |
| 06/27/2001 | EP1111068A1 Branched compound for use in nucleic acid detection and analysis reactions |
| 06/27/2001 | EP1111062A1 Nucleotide sequences encoding the gene zwa1 |
| 06/27/2001 | EP1111060A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 06/27/2001 | EP1111056A2 Process for activating a kinase |
| 06/27/2001 | EP1111054A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
| 06/27/2001 | EP1111048A2 Neutral amino acid transporter and gene thereof |
| 06/27/2001 | EP1111044A1 Method for synthesizing dna |
| 06/27/2001 | EP1111043A1 New QTL's on chromosomes X, 2, 6 and 7 of pigs |
| 06/27/2001 | EP1111040A1 Infection of eukaryotic cells with viruses in vitro |
| 06/27/2001 | EP1110090A1 Multihued labels |
| 06/27/2001 | EP1110088A1 Energy transfer dyes |
| 06/27/2001 | EP1109938A1 Dna amplification of a single cell |
| 06/27/2001 | EP1109937A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 06/27/2001 | EP1109935A2 Two-colour differential display, used as a method for detecting regulated genes |
| 06/27/2001 | EP1109934A1 Amplification of dna with a control sequence differing in gc content |
| 06/27/2001 | EP1109933A1 Method for monitoring the temperature of a biochemical reaction |
| 06/27/2001 | EP1109932A1 Methods for detecting and measuring spliced nucleic acids |